Referencias►
1.
Kagan VE, Shvedova A, Serbinova E, et al. Dihydrolipoic acid - a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl, and chromanoxyl radicals.
Biochem Pharmacol. 1992;44:1637 - 1649.
2.
Matsugo S, Yan LJ, Han D, et al. Elucidation of antioxidant activity of alpha-lipoic acid toward hydroxyl radical.
Biochem Biophys Res Commun. 1995;208:161 - 167.
3.
Packer L, Witt EH, Tritschler HJ. Alpha - lipoic acid as a biological antioxidant.
Free Radic Biol Med. 1995;19:227 - 250.
4.
Podda M, Tritschler HJ, Ulrich H, et al. Alpha - lipoic acid supplementation prevents symptoms of vitamin E deficiency.
Biochem Biophys Res Commun. 1994;204:98 - 104.
5.
Kagan VE, Shvedova A, Serbinova E, et al. Dihydrolipoic acid - a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl, and chromanoxyl radicals.
Biochem Pharmacol. 1992;44:1637 - 1649.
6.
Ziegler D, Hanefeld M, Ruhnau KJ, et al. The ALADIN III Study Group. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study).
Diabetes Care.
1999;22:1296 - 1301.
7.
Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Diabetologia. 1995;38:1425 - 1433.
8.
Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Diabetes. 1997;46(suppl 2):S62 - S66.
9.
Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Diabetes. 1997;46(suppl 2):S62 - S66.
10.
Jacob S, Henriksen EJ, Schiemann AL, et al. Enhancement of glucose disposal in patients with type 2 diabetes by alpha - lipoic acid.
Arzneimittelforschung. 1995;45:872 - 874.
11.
Kawabata T, Packer L. Alpha-lipoate can protect against glycation of serum albumin, but not low density lipoprotein.
Biochem Biophys Res Commun. 1994;203:99 - 104.
12.
Nagamatsu M, Nickander KK, Schmelzer JD, et al. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.
Diabetes Care. 1995;18:1160 - 1167.
13.
Suzuki YJ, Tsuchiya M, Packer L. Lipoate prevents glucose-induced protein modifications.
Free Radic Res Commun. 1992;17:211 - 217.
14.
Jacob S, Ruus P, Hermann R, et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial.
Free Radic Biol Med.
1999;27:309 - 314.
15.
Seidman MD, Khan MJ, Bai U, et al. Biologic activity of mitochondrial metabolites on aging and age-related hearing loss.
Am J Otol.
2000;21:161 - 167.
16.
Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group.
Diabetes Care.
1999;22:1296 - 1301.
17.
Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Diabetologia. 1995;38:1425 - 1433.
18.
Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Diabetes. 1997;46(suppl 2):S62 - S66.
19.
Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Diabetes. 1997;46(suppl 2):S62 - S66.
20.
Kahler W, Kuklinski B, Ruhlmann C, et al. Diabetes mellitus - a free radical - associated disease. Results of adjuvant antioxidant supplementation [in German; English abstract].
Z Gesamte Inn Med. 1993;48:223 - 232.
21.
Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Diabetologia. 1995;38:1425 - 1433.
22.
Packer L, Witt EH, Tritschler HJ. Alpha - lipoic acid as a biological antioxidant.
Free Radic Biol Med. 1995;19:227 - 250.
23.
Ruhnau KJ, Meissnert HP, Finn JR, et al. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy.
Diabet Med.
1999;16:1040 - 1043.
24.
Hounsom L, Horrobin DF, Tritschler H, et al. A lipoic acid - gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy.
Diabetologia. 1998;41:839 - 843.
25.
Cameron NE, Cotter MA, Horrobin DH, et al. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: Interaction with essential fatty acids.
Diabetologia. 1998;41:390 - 399.
26.
Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Diabetes. 1997;46(suppl 2):S62 - S66.
27.
Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group.
Diabetes Care.
1999;22:1296 - 1301.
28.
Dincer Y, Telci A, Kayali R, Yilmaz IA, et al. Effect Of alpha-Lipoic Acid On Lipid Peroxidation And Anti-Oxidant Enzyme Activities In Diabetic Rats.
Clin Exp Pharmacol Physiol.
2002;29:281-284.
29.
Melhem MF, Craven PA, Liachenko J, et al. Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes.
J Am Soc Nephrol.
2002;13:108-116.
30.
Femiano F, Scully C. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy.
J Oral Pathol Med.
2002;31:267-269.
31.
Filina AA, Davydova NG, Endrikhovskii SN, et al. Lipoic acid as a means of metabolic therapy of open-angle glaucoma.
Vestn Oftalmol. 1995;111:6 - 8.